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ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1 
related tumors. 
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We report for the first time DICER1 mutations in two infantile cerebellar embryonal tumors not 
otherwise specified (NOS). Two girls, aged 11 months (case 1) and 8 months (case 2) presented with 
psychomotor delay. Both MRIs showed a midline posterior fossa tumor (Fig.1 ab). After gross total 
resection of the tumor, case 1 was treated with 2 cycles of etoposide/carboplatin. The controlled 
MRI showed spinal and leptomeningeal metastasis. After a subtotal resection, case 2 was treated 
according to institutional protocol for infant with high risk CNS PNET. MRI showed an increase of the 
residual mass during maintenance chemotherapy. 
Case 1 had histological features of ETMR with an architectural pattern of embryonal tumor with 
abundant neuropil and true rosettes (Fig. 1fhjl). For case 2, a similar histology was seen but no true 
rosette was identified (Fig. 1gikm). In spite of LIN28A immunopositivity, FISH and array CGH failed to 
detect C19MC locus amplification [6]. LIN28A immunopositivity is not exclusive to ETMR, but also 
occurs in other tumors such as atypical teratoid/rhabdoid tumors (ATRT), ependymomas, and high 
grade gliomas [6]. ATRT was ruled out by INI1 and BRG1 nuclear immunopositivity in both cases. The 
genomic profile showed a chromosome 2 gain in both cases (Fig. 1cd): this feature is observed in 
about 60% of ETMR [6]. The panel review diagnosis was ETMR NOS for case 1 and CNS embryonal 
tumor NOS for case 2. 
Targeted gene sequencing on tumor DNA identified hotspot mutations corresponding to the RNAse 
IIIb domain of DICER1 in both tumors, DICER1 c.5437G>A / p.(Glu1813Lys) and c.5113G>A / 
p.(Glu1705Lys) (NM_030621.4) in case 1 and 2, respectively. Germline nonsense pathogenic variants 
were then retrieved in both children: c.5053C>T / p.(Gln1685*) and c.1200G>A / p.(Trp400*) in case 
1 and 2, respectively. Mutations in DICER1 in other tumor types commonly follow the same pattern 
of one germline truncating mutation and a somatic missense mutation in the RNase IIIb domain [2, 5, 
7]. No feature of DICER1 syndrome was observed in either family, in accordance with its low 
penetrance (3). The tumor from case 1 also had the pathogenic variant c.134C>T / p.(Ser45Phe) in 
the CTNNB1 gene. No additional alterations were observed in either tumor on our panel 
(Supplementary Table 1). 
Germline DICER1 pathogenic variants predispose to a broad spectrum of benign and malignant 
tumors [5]. Chondroid differentiation is a frequent feature in DICER1 associated tumors such as nasal 
chondromesenchymal hamartoma, rhabdomyosarcoma or anaplastic sarcoma of the kidney [2, 5, 7] 
and was observed in case 2 (Fig. 1kl). Rare CNS embryonal tumors have been described in DICER1 
syndrome including pineoblastoma, pituitary blastoma and ciliary body medulloepithelioma [5]. The 
posterior fossa localization excluded these diagnoses. Interestingly, medulloepithelioma architectural 
pattern is one of the three architectural patterns of ETMR. This subtype is LIN28A+ and may not have 
C19MC alterations. WHO guidelines classify such tumors not as ETMR NOS but as 
medulloepithelioma, suggesting a different oncogenetic entity. A molecular signature still needs to 
be found. We hypothesize that DICER1 mutations may have similar effects to C19MC amplification, in 
at least some medulloepitheliomas, ETMR NOS or embryonal tumors NOS. For case 2, showing a 
focal muscular differentiation, we considered primary intracranial spindle cell sarcoma with 
rhabdomyosarcoma-like features, DICER1 mutant (SCS-RMSlike-DICER1), but smooth muscle actin 
was detected in all the 17 reported cases and was negative in our case [2]. Moreover, this sarcoma 
was located supratentorially in 20/22 cases with a median age of 6 years contrasting with our 
cerebellar infantile case [2]. 
Using the Heidelberg DNA methylation-based CNS tumor classifier, no class prediction was obtained 
with the confidence threshold of ≥ 0.9 [1]. The closest entity was ETMR with scores of 0.3 and 0.2 in 
case 1 and 2, respectively (Methylation data: http://www.ncbi.nlm.nih.gov/geo ; GSE120122). Using 
unsupervised t-SNE analysis, both cases were distinct from SCS-RMSlike-DICER1 and intraocular 
medulloepithelioma and clustered with ETMR (Fig. 1e)[3, 4]. 
We recommend screening for somatic and germline DICER1 pathogenic variants in all CNS embryonal 
tumors NOS, especially if they are LIN28A+, show chondroid differentiation, or are with any tumor of 
DICER1 syndrome spectrum. Identification of DICER1 mutations has implications in terms of genetic 
counseling and surveillance for patients and families [5]. 
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Legends 
Figure 1: For case 1 (a) and case 2 (b), MRI showed a voluminous midline posterior fossa mass, 
enhancing after contrast injection. Array CGH using agilent 180k chip showed chromosome 2 gain, 
4q(92,22-93,43 Mb) segmental gain and 7q(109,41-158,58 Mb) segmental loss in case 1 (c), and 
chromosome 2 gain in case 2 (d). t-SNE analysis (e). H&E showed small undifferentiated monotonous 
cells with numerous mitoses and apoptotic bodies (f: case1, g: case 2) and a biphasic histological 
pattern with areas of small embryonal perivascular cells and neuropil-like areas (h: case 1, i: case 2). 
In case 1, multilayered rosettes (left) and true rosettes (arrows) were observed (j). Foci of chondroid 
(left) and rhabdomyoblastic (right) differentiation were seen in case 2. Detail: desmin 
immunostaining (k). Strong LIN28A immunostaining: case 1 (l), case 2 (m). 
Supplementary Table 1: Listing of the 78 childhood cancer genes of the targeted gene sequencing 
panel (Illumina_TruSeq Custom Amplicon)  
 
